1887

Abstract

The objective of this study was to examine the protective efficacy of purified recombinant herpes simplex virus type 1 (HSV-1) glycoprotein E (gE-1) in the mouse lethal challenge model. A secreted form of gE-1 (hgE-1s) protein, containing amino acids 1-406, was produced in human cells by using the episomal replicating pRP-RSV expression vector. In addition, a portion of the gE-1 (bgE-1t) protein corresponding to amino acids 90-406, was expressed in as a fusion protein with maltose binding protein using the pMAL-c2 expression vector. Mice vaccinated with hgE-1s developed high serum titres of HSV-1-neutralizing antibodies and were significantly protected from intraperitoneal lethal HSV-1 challenge, whereas mice vaccinated with bgE-1t exhibited only moderate levels of protective immunity. These results demonstrate that the expression of gE-1 in human cells has a strong impact on its protective efficacy and that most importantly the hgE-1s protein could be of value as a component of an HSV multi-subunit vaccine.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-76-12-3137
1995-12-01
2021-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/76/12/JV0760123137.html?itemId=/content/journal/jgv/10.1099/0022-1317-76-12-3137&mimeType=html&fmt=ahah

References

  1. Adler R., Glorioso J. C., Cossman J., Levine M. 1978; Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis. Infection and Immunity 21:442–447
    [Google Scholar]
  2. Balan P., Davis-Poynter N., Bell S., Atkinson H., Browne H., Minson T. 1994; An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus 1 lacking glycoproteins gG, gE, gI or the putative gJ. Journal of General Virology 75:1245–1258
    [Google Scholar]
  3. Baucke R. B., Spear P. G. 1979; Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc binding glycoprotein. Journal of Virology 32:779–789
    [Google Scholar]
  4. Bell S., Cranage M., Borysiewicz L., Minson T. 1990; Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1. Journal of Virology 64:2181–2186
    [Google Scholar]
  5. Berman P. W., Crase D., Lasky L. A. 1984; Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science 227:1490–1492
    [Google Scholar]
  6. Blacklaws B. A., Krishna S., Minson A. C., Nash A. A. 1990; Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177:727–736
    [Google Scholar]
  7. Burke R. L. 1991; Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use. Reviews of Infectious Diseases 13: (supplement 11) 906–911
    [Google Scholar]
  8. Burke R. L. 1993; Current developments in herpes simplex virus vaccines. Seminars in Virology 4:187–197
    [Google Scholar]
  9. Dingwell K. S., Brunetti C. R., Hendricks R. L., Tang Q., Tang M., Rainbow A. J., Johnson D. C. 1994; Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. Journal of Virology 68:834–845
    [Google Scholar]
  10. Dubin G., Socolof E., Frank I., Friedman H. M. 1991; Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. Journal of Virology 65:7046–7050
    [Google Scholar]
  11. Dubin G., Basu S., Mallory D. L. P., Basu M., Tal-Singer R., Friedman H. M. 1994; Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. Journal of Virology 68:2478–2486
    [Google Scholar]
  12. Frank I., Friedman H. M. 1989; A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. Journal of Virology 63:4479–1488
    [Google Scholar]
  13. Ghiasi H., Kaiwar R., Nesburn A. B., Wechsler S. L. 1991; Expression of herpes simplex virus type 1 glycoprotein B in insect cells. Initial analysis of its biochemical and immunological properties. Virus Research 22:25–39
    [Google Scholar]
  14. Ghiasi H., Kaiwar R., Nesburn A. B., Wechsler S. L. 1992a; Baculovirus-expressed herpes simplex virus type 1 glycoprotein C protects mice from lethal HSV-1 infection. Antiviral Research 18:291–302
    [Google Scholar]
  15. Ghiasi H., Kaiwar R., Nesburn A. B., Slanina S., Wechsler S. L. 1992b; Baculovirus-expressed glycoprotein E (gE) of herpes simplex virus type-1 (HSV-1) protects mice against lethal intraperitoneal and lethal ocular HSV-1 challenge. Virology 188:469–476
    [Google Scholar]
  16. Ghiasi H., Kaiwar R., Nesburn A. B., Slanina S., Wechsler S. L. 1994a; Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. Journal of Virology 68:2118–2126
    [Google Scholar]
  17. Ghiasi H., Slanina S., Nesburn A. B., Wechsler S. L. 1994b; Characterization of baculovirus-expressed herpes simplex virus type 1 glycoprotein K. Journal of Virology 68:2347–2354
    [Google Scholar]
  18. Johnson D. C., Feenstra V. 1987; Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. Journal of Virology 61:2208–2216
    [Google Scholar]
  19. Johnson D. C., Frame M. C., Ligas M. W., Cross A. M., Stow N. D. 1988; Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. Journal of Virology 62:1347–1354
    [Google Scholar]
  20. Kino Y. 1990; Yeast derived glycoprotein B-1 of herpes simplex virus (HSV) as a candidate for an HSV vaccine. Advances in Experimental Biology and Medicine 278:183–190
    [Google Scholar]
  21. Krishna S., Blacklaws B. A., Overton H. A., Bishop D. H. L., Nash A. A. 1989; Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts. Journal of General Virology 70:1805–1814
    [Google Scholar]
  22. Langenberg A. G. M., Burke R. L., Adair S. F., Sekulovich O., Tigges M., Dekker C. L., Corey L. 1995; A recombinant glycoprotein vaccine for herpes simplex type 2: safety and efficacy. Annals of Internal Medicine 122:889–898
    [Google Scholar]
  23. Laurence L. A., Dowbenko D., Simonsen C. C., Berman P. W. 1984; Protection of mice from lethal herpes simplex virus infection by vaccination with a secreted form of cloned glycoprotein D. BioTechnology 2:527–532
    [Google Scholar]
  24. Lehman D. J., Roof L. L., Brideau R. J., Aeed P. A., Thomsen D. R., Elhammer A. P., Wathen M. W., Homa F. L. 1993; Comparison of soluble and secreted forms of human parainfluenza virus type 3 glycoproteins expressed from mammalian and insect cells as subunit vaccines. Journal of General Virology 74:459–469
    [Google Scholar]
  25. Manservigi R., Grossi M. P., Gualandri R., Balboni P. G., Marchini A., Rotola A., Rimessi P., Di Luca D., Cassai E., Barbanti-Brodano G. 1990; Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector. Journal of Virology 64:431–436
    [Google Scholar]
  26. Martin S., Cantin E., Rouse B. T. 1989; Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins. Journal of General Virology 70:1359–1370
    [Google Scholar]
  27. Para M. F., Baucke R. B., Spear P. G. 1982; Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus induced Fc-binding receptors. Journal of Virology 41:129–136
    [Google Scholar]
  28. Pachl C., Burke R. L., Stuve L. L., Sanchez-Pescador L., Van Nest G., Masiarz F., Dina D. 1987; Expression of cell- associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells. Journal of Virology 61:315–325
    [Google Scholar]
  29. Post L. E., Conley A. J., Mocarski E. S., Roizman B. 1980; Cloning of reiterated and non reiterated herpes simplex 1 sequences as Bam HI fragments. Proceedings of the National Academy of Sciences, USA 11:4201–205
    [Google Scholar]
  30. Rose J. K., Shafferman A. 1981; Conditional expression of the vesicular stomatitis virus glycoprotein gene in Escherichia coli . Proceedings of the National Academy of Sciences, USA 78:6670–6674
    [Google Scholar]
  31. Stanberry L. R. 1995; Herpes simplex virus vaccines as immuno- therapeutic agents. Trends in Microbiology 3:244–247
    [Google Scholar]
  32. Stanberry L. R., Myers M. G., Stephanopoulos D. E., Burke R. L. 1989; Preinfection prophylaxis with herpes simplex virus glycoprotein immunogens: factors influencing efficacy. Journal of General Virology 70:3177–3185
    [Google Scholar]
  33. Straus S. E., Corey L., Burke R. L., Savarese B., Barnum G., Krause P. R., Kost R. G., Meier J. L., Sekulovich R., Adair S. F., Dekker C. L. 1994; Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 343:1460–1463
    [Google Scholar]
  34. Weir J. P., Bennett M., Allen E. M., Elkins K. L., Martin S., Rouse B. T. 1989; Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein G protects mice against herpes simplex virus challenge. Journal of General Virology 70:2587–2594
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-76-12-3137
Loading
/content/journal/jgv/10.1099/0022-1317-76-12-3137
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error